Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Koya Medical is a private medtech company focused on venous and lymphatic disease, developing wearable active compression treatments intended to improve mobility, adherence, and outcomes compared with traditional compression approaches. Its flagship commercial product is the Dayspring system, an FDA-cleared non-pneumatic compression device used in lymphedema and related chronic edema care. The company is positioning itself more broadly in vascular health with solutions spanning lymphatic and venous conditions, including chronic venous insufficiency and chronic occlusive disease. Koya combines hardware, garments, software, and clinical evidence generation to support adoption among providers, patients, and payors. Founded in 2018, the company has grown from its Oakland origins and opened a larger headquarters in Dallas as it scales commercialization.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Koya Medical.